Summerlin Hospital Adds New Technology to Improve Detection of Certain Bladder Cancers
Wednesday, June 20, 2018
In its ongoing commitment to the detection and treatment of cancer, Summerlin Hospital now offers Blue Light Cystoscopy with Cysview®, an optical imaging agent for the detection of papillary cancer of the bladder in patients with known or suspected bladder cancer. Cysview is the only FDA-approved imaging agent for use with blue-light cystoscopy.